Nippon India Pharma Fund-Growth Plan-Growth Option

Nippon India Pharma Fund-Growth Plan-Growth Option - Portfolio Analysis

Portfolio Overview

As of April 30, 2026

Icon Portfolio

Asset Allocation

Equity: 98.68%Others: 1.32%
Icon Portfolio

Market Cap

Large Cap: 32.97%Mid Cap: 37.85%Small Cap: 26.90%Others: 0.96%
Icon Portfolio

Number of stocks

35
Icon Portfolio

Top 10 Holdings

59.53% of portfolio

Market Cap of Equity

Large Cap
32.97%
Mid Cap
37.85%
Small Cap
26.90%
Others
0.96%

Companies Allocation of Equity

Sun Pharmaceuticals Industries Ltd13.85%
Lupin Ltd7.95%
Dr Reddy's Laboratories Ltd7.04%
Divi's Laboratories Ltd6.61%
Cipla Ltd5.47%
Apollo Hospitals Enterprise Ltd5.01%
Medplus Health Services Ltd3.78%
Vijaya Diagnostic Centre Ltd3.36%
Sai Life Sciences Ltd3.27%
Ajanta Pharma Ltd3.19%

Sector Allocation of Equity

Healthcare98.68%

SIP Amount

Monthly SIP Date

Nippon India Pharma Fund-Growth Plan-Growth Option

Suitabilty Test For Finding this Fund is Suitable or Not for User.Suitabilty Test For Finding this Fund is Suitable or Not for User.
Is This Mutual Fund Right for You?

+10k investors used our Suitability Test to get better returns

Frequently Asked Questions

Everything You Need To Know To Get Started With Confidence

In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.

All-in-one Mutual Fund Investing app for everyone.

Start your Investing Journey Today.

App StoreGoogle Play